Myriad’s myPath® Melanoma Test Receives Medicare Coverage

NEXT STORY
Global Pediatric Vaccine Market Analysis & Forecast (2019-2023) by Product, Type and Geography with Key Player Profiles
PREV STORY
electroCore Announces Encouraging Research Supporting Key Areas of Clinical Development for its Non-Invasive Vagus Nerve Stimulator, gammaCore™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients

author_avatar
NASDAQ Market News

Roche announces FDA grants Venclexta accelerated approval for people with newly-diagnosed acute myeloid leukaemia or those who are ineligible for intensive induction chemotherapy

Approval based on two studies that showed durable remissions in people with newly-diagnosed acute ...

author_avatar
NASDAQ Market News

Chembio Diagnostics Announces $20 Million Term Loan with Perceptive Advisors

author_avatar
NASDAQ Market News